Mekanika, founded by David Holmes, Chairman and Chief Science Officer, has invested over 20 years of R&D on the Mekanika Spinal Restabilization System, a revolutionary advancement in the diagnosis and treatment of spinal instability. The company was founded within the renowned University of Miami’s Orthopaedic Surgery Department, where Mr. Holmes was Director of the Spine Biomechanics Research Lab. The Spinal Stiffness Gauge (SSG) was patented and developed to allow an accurate, objective, intra-operative, computer-based measurement of spine joint instability before and after spinal decompression. The SSG was used at the University of Miami in over 300 patients undergoing spine surgery to demonstrate the accuracy and value of the measurement, which may become the needed, essential definition of spinal instability used to guide and document the necessity for fusion, restabilization or just the decompression. A database of SSG measurements has been developed from the test results in 300 patients, and can be reviewed in the May 2002 issue of SPINE.
Further research in the area of spinal instability led Mr. Holmes to realize that fusion was not the optimum method of spinal stabilization. He designed and patented the Modulus™ Spinal Reconstruction System. Not only is this device capable of being used in fusion, but it is the first, posterior, intrasegmental arthroplasty system on the market designed to restabilize the spine joint while maintaining segmental motion and normal biomechanical function. FDA IDE studies are anticipated to begin in 2004. Spine arthroplasty has been cited as the new frontier of orthopedics. http://mekanika.com
About the Spinal Market
The Spinal implants and spinal devices market, by technology, includes spinal fusion and fixation, vertebral compression fracture treatment, and motion preservation/non-fusion technologies. On the basis of products, the global spinal implants and spinal devices market is divided into six major segments, namely, thoracic fusion and lumbar fusion devices, cervical fusion devices, spine biologics, vertebral compression fracture treatment devices, motion preservation/non-fusion treatment devices, and spine bone stimulators. Bases on the type of surgery, the global spinal implants and spinal devices market is divided into two segments, namely, open surgery and minimally invasive surgery. The spinal decompression devices market, by type of procedure, covers discectomy, laminotomy/laminectomy, foraminotomy/foraminectomy, facetectomy, and corpectomy procedures.
The Spinal market is expected to reach USD 15.73 Billion by 2020, growing at a CAGR of 5.6% from 2015 to 2020. As of 2015, North America is estimated to hold the largest share of the global spinal implants and spinal devices market, followed by Europe. However, the Asia-Pacific market is expected to grow at the highest CAGR of 8.2% from 2015 to 2020. A number of factors, including rising healthcare expenditure in developing nations owing to growing income levels, increasing government funding, presence of a large patient population, rising obesity cases, and growing awareness on the newly developed spine treatment techniques and devices are propelling the growth of the spinal implants and spinal devices market in the Asia-Pacific region. However, challenges associated with this market, such as scarcity of expertise and trained healthcare workers and lack of adequate patient awareness restricts the market growth in this region.
Source: marketsandmarkets.com